TITLE

Week in Washington

PUB. DATE
November 2012
SOURCE
BioWorld Insight;11/ 5/2012, Vol. 20 Issue 45, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the U.S. Food & Drug Administration has approved the drug Synribo for treatment of chronic myelogenous leukemia which will be marketed by Teva Pharmaceutical Industries Ltd.
ACCESSION #
83291331

 

Related Articles

  • Teva: GSK's latest headache.  // PharmaWatch: CNS;Jan2007, Vol. 6 Issue 1, p16 

    The article focuses on the tentative approval received by Teva Pharmaceutical Industries Ltd. for sumatriptan succinate anti-migraine drug from the U.S. Food and Drug Administration. The firm has become the latest addition to companies that aim to challenge the Imitrex drug of GlaxoSmithKline....

  • First-time generic approval.  // Formulary;Aug2009, Vol. 44 Issue 8, p224 

    The article reports that Ethinyl estradiol/norgestimate tablets from Teva Pharmaceutical Industries Ltd. has got the approval of the Food & Drug Administration (FDA) of the U.S.

  • FDA approves Teva's one-pill emergency contraceptive. Johnsen, Michael // Drug Store News;8/10/2009, Vol. 31 Issue 9, p83 

    The article reports on the approval for the emergency contraceptive Plan B One-Step from Teva Pharmaceuticals Industries Ltd. by the Food and Drug Administration (FDA) in the U.S. It notes that the product is a line extension of Plan B which changes the two-pill regimen to one pill. It adds that...

  • Teva Launches Generic Lovaza Capsules in the U.S.  // Nutraceuticals World;May2014, Vol. 17 Issue 4, p20 

    The article reports that pharmaceutical company Teva Pharmaceutical Industries Ltd. has announced the approval of its generic drugs for Lovaza capsules by the U.S. Food and Drug Administration (FDA) in 2014.

  • Teva receives FDA approval to market generic Aricept tablets.  // PharmaWatch: CNS;Jul2011, Vol. 10 Issue 7, p9 

    The article reports on the approval given by the U.S. Food and Drug Administration (FDA) to market the new abbreviated drug application (ANDA) of Teva Pharmaceutical Industries Ltd. which is the generic version of Aricept tablets for the treatment of Alzheimer's disease.

  • Zoloft patent expiration sparks battle royal.  // Drug Topics;7/24/2006, Vol. 150 Issue 14, p8 

    The article reports that the U.S. Food and Drug Administration has approved the generic version of Zoloft antidepressants of Teva Pharmaceutical Industries Ltd. and Roxane Laboratories Inc. Teva's version of the drug is in tablet form while Roxane's version of it is in liquid form. This move of...

  • Generic approvals may set off statin storm. LoBuono, Charlotte // Drug Topics;7/24/2006, Vol. 150 Issue 14, p10 

    The article reports on the approval of several generic versions of simvastatin by the U.S. Food and Drug Administration. Teva Pharmaceutical Industries Ltd. is gaining an exclusive rights to sell several dosages of simvastatin. Ranbaxy Pharmaceuticals Inc. is acquiring rights to sell 80...

  • Pharma in Brief.  // Chemical Market Reporter;9/8/2003, Vol. 264 Issue 7, p7 

    Reports that Teva Pharmaceutical Industries Inc. and GlaxoSmithKline have received U.S. Food and Drug Administration approval for drug application.

  • Action Delayed On Teva Drug.  // Chain Drug Review;10/25/2010, Vol. 32 Issue 18, p81 

    The article reports on the decision of the U.S. Food and Drug Administration in postponing the approval of Teva Pharmaceutical Industries Ltd.'s biotechnology medicine to promote white blood cells that is similar to Amgen Inc.'s Neupogen.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics